Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05901493 · ClinicalTrials.gov registry record · NA
Category Learning Retention in Adults With and Without Developmental Language Disorder
A NA study of Developmental Language Disorder and Adults Without Language Disorder, sponsored by University of Delaware.
- Recruiting
- Registry status
- NA
- Development phase
- 540
- Enrollment target
- 2
- Study locations
NCT05901493: Recruiting NA study of Developmental Language Disorder and Adults Without Language Disorder, sponsored by University of Delaware.
NCT05901493 is a NA study of Developmental Language Disorder and Adults Without Language Disorder that is actively recruiting participants, run by University of Delaware. The registered enrollment target is 540 participants, above the 151-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (258% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05901493, a NA study of Developmental Language Disorder and Adults Without Language Disorder, is actively recruiting participants, sponsored by University of Delaware.
- RECRUITING
- Registry status
- NA
- Development phase
- 540 participants
- Enrollment target
- 2
- Study locations
Study Summary
Approximately 7% of the population experiences developmental language disorder (DLD), a language disorder with unclear causes. DLD affects communication beyond adolescence and poses challenges for education and career advancement due to difficulties in learning and memory. Recent research suggests that adults with DLD struggle with overnight memory consolidation, indicating a need for effective learning and memory support. This project aims to determine the optimal training schedule for perceptual memory retention in adults with and without DLD. The study involves recruiting 240 adults (120 with DLD, 120 without) for speech-perceptual training with different training schedules. The researchers predict that the manipulation of training schedules will interact with circadian preference and overnight consolidation, leading to the discovery of the best practice schedule for speech sound retention. Additionally, 300 more adults (150 with DLD, 150 without) will be recruited to investigate how optimal training schedules interact with reflexive and reflective learning strategies. The time course of learning and retention will be tracked during reflexive and reflective categorization training in six different training schedules.
Primary Outcome
Participants will be administered a short (approximately 4-minute) behavioral task. They will be exposed to two speech sounds, separated by a 1-second interval. Some sounds will begin with the dental stop consonant, and other sounds will begin with the retroflex stop consonant. Participants will be asked to decide if the two sounds they hear are the same or different. Accuracy will be converted to d-prime (a measure of signal detection). This d-prime score will be the primary behavioral outcome
Conditions Studied
Interventions
- BEHAVIORAL Perceptual category training
Study Locations (2)
Delaware
- University of Delaware - Newark
Massachusetts
- Northeastern University - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 540 participants |
| Start Date | 2022-10-23 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
What NCT05901493 shows while recruiting
NCT05901493 is an interventional study that assigns participants to a tested intervention. The registered 540 participants enrollment target is mid-sized for trials with a published cap, above the 151-participant average among 17 other Developmental Language Disorder trials with a reported enrollment target (258% higher).
The record links to 2 conditions, with Developmental Language Disorder appearing as the primary indexed condition, and to 1 intervention - of which Perceptual category training is the first listed.
NCT05901493 reports a single indexed study location in Delaware, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05901493 about?
NCT05901493 is a clinical study titled "Category Learning Retention in Adults With and Without Developmental Language Disorder". Approximately 7% of the population experiences developmental language disorder (DLD), a language disorder with unclear causes. DLD affects communication beyond adolescence and poses challenges for education and career advancement due to difficulties in learning and memory. Recent research suggests t...
What is the current status of trial NCT05901493?
This trial is currently recruiting. It is a NA study. The enrollment target is 540 participants. The study started on 2022-10-23. Estimated completion is 2027-07-31.
What conditions does trial NCT05901493 study?
This clinical trial studies the following conditions: Developmental Language Disorder, Adults Without Language Disorder.
What interventions are being tested in trial NCT05901493?
The interventions under investigation include: Perceptual category training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05901493?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05901493 being conducted?
This trial has 2 study locations across Delaware, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Developmental Language Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05901493's enrollment target sits among peer trials
540 1st of 17 higher than 17 of 17 other Developmental Language Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Developmental Language Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Contextual Word Learning in Children With Developmental Language Disorder
RECRUITING · NA
-
Emergent Bilinguals: Child Language Proficiency and Language of Treatment
RECRUITING · NA
-
Neuroimaging Reveals Treatment-related Changes in DLD
RECRUITING · NA
-
The Short-term Verbal Memory Endophenotype for Developmental Language Disorder Language Disorder
RECRUITING · NA
-
A Developmental Framework For Linking Phonological And Morpho-syntactic Sequential Pattern Rules In DLD: Production
RECRUITING · NA
-
Optimizing Feedback-based Learning in Children With Developmental Language Disorder
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04557462 · 540 participants · Phase 3
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
- NCT04956640 · 540 participants · Phase 1
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)
- NCT05429892 · 540 participants · NA
FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers
- NCT05549297 · 540 participants · Phase 3
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI